DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder
The Brown University Psychopharmacology Update · 2026-03 · 37 (3) · 3-4
DOI: 10.1002/pu.31417 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Brown University Psychopharmacology Update, online erschienen am 23.02.2026.
Abstract (Originalsprache)
Six months of dialectical behavior therapy (DBT) was more efficacious than a 6‐month course of treatment with a selective serotonin reuptake inhibitor (SSRI) antidepressant in reducing suicide‐related events in patients with borderline personality disorder, a randomized trial has found. However, SSRI treatment was more efficacious than DBT in reducing diagnoses of major depressive disorder at 6 months.
Zitieren
APA
(2026). DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder. The Brown University Psychopharmacology Update, 37(3), 3-4. https://doi.org/10.1002/pu.31417
Vancouver
DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder. The Brown University Psychopharmacology Update. 2026;37(3):3-4. doi:10.1002/pu.31417
BibTeX
@article{euvimed2026,
title = {DBT more efficacious than SSRI in reducing suicidality in borderline personality disorder},
journal = {The Brown University Psychopharmacology Update},
year = {2026},
volume = {37},
number = {3},
pages = {3--4},
doi = {10.1002/pu.31417}
}
EUVIMED